231 related articles for article (PubMed ID: 21398412)
1. Enhancement of corneal endothelium wound healing by Rho-associated kinase (ROCK) inhibitor eye drops.
Okumura N; Koizumi N; Ueno M; Sakamoto Y; Takahashi H; Hirata K; Torii R; Hamuro J; Kinoshita S
Br J Ophthalmol; 2011 Jul; 95(7):1006-9. PubMed ID: 21398412
[TBL] [Abstract][Full Text] [Related]
2. The ROCK inhibitor eye drop accelerates corneal endothelium wound healing.
Okumura N; Koizumi N; Kay EP; Ueno M; Sakamoto Y; Nakamura S; Hamuro J; Kinoshita S
Invest Ophthalmol Vis Sci; 2013 Apr; 54(4):2493-502. PubMed ID: 23462749
[TBL] [Abstract][Full Text] [Related]
3. The new therapeutic concept of using a rho kinase inhibitor for the treatment of corneal endothelial dysfunction.
Okumura N; Koizumi N; Ueno M; Sakamoto Y; Takahashi H; Hamuro J; Kinoshita S
Cornea; 2011 Oct; 30 Suppl 1():S54-9. PubMed ID: 21912232
[TBL] [Abstract][Full Text] [Related]
4. Involvement of cyclin D and p27 in cell proliferation mediated by ROCK inhibitors Y-27632 and Y-39983 during corneal endothelium wound healing.
Okumura N; Nakano S; Kay EP; Numata R; Ota A; Sowa Y; Sakai T; Ueno M; Kinoshita S; Koizumi N
Invest Ophthalmol Vis Sci; 2014 Jan; 55(1):318-29. PubMed ID: 24106120
[TBL] [Abstract][Full Text] [Related]
5. Effect of the Rho Kinase Inhibitor Y-27632 on Corneal Endothelial Wound Healing.
Okumura N; Inoue R; Okazaki Y; Nakano S; Nakagawa H; Kinoshita S; Koizumi N
Invest Ophthalmol Vis Sci; 2015 Sep; 56(10):6067-74. PubMed ID: 26393474
[TBL] [Abstract][Full Text] [Related]
6. New therapeutic modality for corneal endothelial disease using Rho-associated kinase inhibitor eye drops.
Koizumi N; Okumura N; Ueno M; Kinoshita S
Cornea; 2014 Nov; 33 Suppl 11():S25-31. PubMed ID: 25289721
[TBL] [Abstract][Full Text] [Related]
7. ROCK inhibitor converts corneal endothelial cells into a phenotype capable of regenerating in vivo endothelial tissue.
Okumura N; Koizumi N; Ueno M; Sakamoto Y; Takahashi H; Tsuchiya H; Hamuro J; Kinoshita S
Am J Pathol; 2012 Jul; 181(1):268-77. PubMed ID: 22704232
[TBL] [Abstract][Full Text] [Related]
8. Enhancement on primate corneal endothelial cell survival in vitro by a ROCK inhibitor.
Okumura N; Ueno M; Koizumi N; Sakamoto Y; Hirata K; Hamuro J; Kinoshita S
Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3680-7. PubMed ID: 19387080
[TBL] [Abstract][Full Text] [Related]
9. Effect of the Rho-Associated Kinase Inhibitor Eye Drop (Ripasudil) on Corneal Endothelial Wound Healing.
Okumura N; Okazaki Y; Inoue R; Kakutani K; Nakano S; Kinoshita S; Koizumi N
Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):1284-92. PubMed ID: 26998714
[TBL] [Abstract][Full Text] [Related]
10. Rho-associated kinase inhibitor eye drop treatment as a possible medical treatment for Fuchs corneal dystrophy.
Koizumi N; Okumura N; Ueno M; Nakagawa H; Hamuro J; Kinoshita S
Cornea; 2013 Aug; 32(8):1167-70. PubMed ID: 23715376
[TBL] [Abstract][Full Text] [Related]
11. Y-27632 Promotes the Repair Effect of Umbilical Cord Blood-Derived Endothelial Progenitor Cells on Corneal Endothelial Wound Healing.
Zhang W; Shao C; Yu F; Chen J; Fu Y; Fan X
Cornea; 2021 Feb; 40(2):203-214. PubMed ID: 33086282
[TBL] [Abstract][Full Text] [Related]
12. A selective inhibitor of the Rho kinase pathway, Y-27632, and its influence on wound healing in the corneal stroma.
Yamamoto M; Quantock AJ; Young RD; Okumura N; Ueno M; Sakamoto Y; Kinoshita S; Koizumi N
Mol Vis; 2012; 18():1727-39. PubMed ID: 22815626
[TBL] [Abstract][Full Text] [Related]
13. ROCK inhibitor enhances adhesion and wound healing of human corneal endothelial cells.
Pipparelli A; Arsenijevic Y; Thuret G; Gain P; Nicolas M; Majo F
PLoS One; 2013; 8(4):e62095. PubMed ID: 23626771
[TBL] [Abstract][Full Text] [Related]
14. Human corneal endothelium regeneration: effect of ROCK inhibitor.
Galvis V; Tello A; Gutierrez ÁJ
Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4971-3. PubMed ID: 23883789
[No Abstract] [Full Text] [Related]
15. Author response: Human corneal endothelium regeneration: effect of ROCK Inhibitor.
Koizumi N; Okumura N; Kinoshita S
Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5594-5. PubMed ID: 23960040
[No Abstract] [Full Text] [Related]
16. Potential role of Rho-associated protein kinase inhibitor Y-27632 in glaucoma filtration surgery.
Honjo M; Tanihara H; Kameda T; Kawaji T; Yoshimura N; Araie M
Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5549-57. PubMed ID: 18055804
[TBL] [Abstract][Full Text] [Related]
17. The Role of Rho Kinase Inhibitors in Corneal Endothelial Dysfunction.
Okumura N; Kinoshita S; Koizumi N
Curr Pharm Des; 2017; 23(4):660-666. PubMed ID: 27917718
[TBL] [Abstract][Full Text] [Related]
18. Development of new therapeutic modalities for corneal endothelial disease focused on the proliferation of corneal endothelial cells using animal models.
Koizumi N; Okumura N; Kinoshita S
Exp Eye Res; 2012 Feb; 95(1):60-7. PubMed ID: 22067130
[TBL] [Abstract][Full Text] [Related]
19. ERK1/2 activation regulates the wound healing process of rabbit corneal endothelial cells.
Chen WL; Lin CT; Li JW; Hu FR; Chen CC
Curr Eye Res; 2009 Feb; 34(2):103-11. PubMed ID: 19219681
[TBL] [Abstract][Full Text] [Related]
20. Y-27632, a ROCK Inhibitor, Promoted Limbal Epithelial Cell Proliferation and Corneal Wound Healing.
Sun CC; Chiu HT; Lin YF; Lee KY; Pang JH
PLoS One; 2015; 10(12):e0144571. PubMed ID: 26673160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
